Odit Gutwein

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL.

Journal: Blood advances

Published: July 14, 2025

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Journal: American journal of hematology

Published: June 25, 2023

Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.

Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.

Journal: Cancer medicine

Published: April 18, 2023

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study.

Journal: American journal of hematology

Published: September 14, 2022

Lymphoproliferative disease detected by breast cancer screening.

Lymphoproliferative disease detected by breast cancer screening.

Journal: Journal of medical screening

Published: July 12, 2022

Haematological patients' perception of home transfusions: Effect of the COVID-19 pandemic.

Haematological patients' perception of home transfusions: Effect of the COVID-19 pandemic.

Journal: Vox sanguinis

Published: May 09, 2022

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.

Journal: Journal of hematology & oncology

Published: April 19, 2022

Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.

Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.

Journal: Research and practice in thrombosis and haemostasis

Published: April 08, 2022

Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.

Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.

Journal: Annals of hematology

Published: February 09, 2022

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.

Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.

Journal: Annals of hematology

Published: October 25, 2021

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Journal: Leukemia

Published: July 28, 2021

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.

BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.

Journal: American journal of hematology

Published: June 17, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026